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SConclusions: Facilitation using ROTA improves peri-procedural success without
increasing complications for severely calciﬁed ULM stenosis. Especially in no HD
patients, excellent results were obtained at 1-year. However, the development of
TLR-MB had still occurred in 38% of the HD patients despite optimal stent
expansion.
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Comparison of Coronary Artery Bypass Surgery, Percutaneous Drug-eluting
Stent Implantation, and Medical Therapy for Unprotected Left Main Coronary
Artery Disease
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Background: Unprotected left main coronary artery (ULMCA) disease is considered
an indication for revascularization. However, in “real-world” clinical practice some
patients receive medical therapy only. The arm of this study was to evaluate long-term
results in patients with ULMCA disease in a “real-world” practice.
Methods: Between January 2006 and June 2011, 218 stable patients were diagnosed
with de novo ULMCA stenosis. 52 (23.9%) patients received medical therapy only,
coronary artery bypass grafting (CABG) was performed in 106 (48.6%) patients,
percutaneous coronary intervention (PCI) in 60 (27.5%) patients. The composite of
death, myocardial infarction, and stroke deﬁned as major adverse cardiac and cere-
brovascular events (MACCE) and target vessel revascularization (TVR) were deﬁned
as primary endpoints. The median follow-up period was 4 years.
Results: Baseline clinical and descriptive morphology of coronary artery disease
revealed more comorbidities and more complex anatomies in the medical therapy group
compare with CABG and PCI groups. Revascularization might not have been used due
to physician's decision (operative risk considered excessive) in 24 (46.2%) cases or
when patients refused revascularization in 28 (53.8%) cases. At 4-year follow-up
MACCE rate was higher in nonsurgical group (34.6%) compare with CABG (13.2%;
p¼0.002) and PCI (14.5%; p¼0.016) groups, but there was no difference between
CABG and PCI groups. Survival in CABG (4.7%; p<0.001) and PCI (5.5%; p¼0.009)
groups was higher in compare with nonsurgical group (23.1%). On the multivariable
Cox regression analysis, coronary revascularization (CABG and PCI) was independent
predictor of long-term survival (HR 3.49; 95% CI 1.39-8.75; P<0.001).
Conclusions: PCI, like CABG improves survival for patients with unprotected left
main coronary artery disease compared with medical therapy only in “real-world”
clinical practice.
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Background: Clinical outcomes after treatment of true bifurcation lesions (Medina
classiﬁcation: 1.1.1, 1.0.1 and 0.1.1) are in general inferior when compared to non-true
bifurcation lesions (1.1.0, 0.0.1, 0.1.0). Therefore, our aim was to compare clinical
outcomes of the patients with true and non-true bifurcation lesions treated with Nobori
DES. This stent with open cell design and bioresorbable polymer is expected to
perform well in lesions involving bifurcation.
Methods: Within the large, prospective, single-arm, multi-centre, eNOBORI registry,
898 patients (1541 lesions) had at least one bifurcation treated. Bifurcation lesions
(BL) were divided into true (TBL, 512 patients; 927 lesions) and non-true bifurcation
lesions (NTBL, 386 patients; 614 lesions). All adverse events are adjudicated by an
independent clinical event committee. Primary endpoint of the study is target lesion
failure (TLF) at 1 year.
Results: Patients in both groups had similar baseline characteristics, except that patients
with TBL were less often male (74.8% vs 81.6%) and presented more often with renal
failure (8.1% vs 4.7%). Average number of lesions treated per patient and stents
implanted per lesion was higher in TBL than in NTBL (2.461.50 vs 2.151.50;
p< 0.01 and 1.280.55 vs. 1.160.43; p< 0.01, respectively). According to theMedina
classiﬁcation, the most frequent lesion type in TBL was [1.1.1] (66.2%), whereas in
NTBL, [1.1.0] type was most abundant (42.9%). Direct stenting was more frequent in
NTBL (35.9%vs. 22.6%; p<0.01) and procedural successwas similar in TBLandNTBL
groups (98.2% vs 99.2%). In the TBL group, 3 patients died (1.0%; cardiac), 5 patients
had TV-MI (1.7%) and 9 patients a TLR (3.0%) at 12 months, resulting int TLF of 6.0%.
In the NTBL group, 1 patient died (0.5%; cardiac), 2 patients had TV-MI (0.9%) and 4
patients a TLR (1.9%), resulting in a TLF of 3.2%. No stent thrombosis were observed in
the NTBL whereas 2 deﬁnite, subacute ST (0.48%) occurred in TBL patients (p¼ NS).
Conclusions: As expected, clinical outcomes after treatment of true bifurcation
lesions were less favorable compared to the non-true bifurcation lesions however, the
results of both cohorts are very good up to one year.B128 JACC Vol 62/18/Suppl B j October 27–November 1, 2TCT-412
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Background: Long term clinical outcomes after biodegradable polymer eluting stents
implantation at bifurcation lesions are unclear.
Methods:We analyzed 203 consecutive patients (208 bifurcation lesions treated) who
were treated with PCI with biodegradable polymer coating biolimus-eluting
stent(BES) exclusively at our institution between February 2005 and April 2009. They
were followed up prospectively after the PCI (median follow-up 1931 days).
Results: One hundred sixty one patients (79%) were male and mean ages were 69 
10.3. LMT lesions were 63(30%). Eighty lesions(38%) were treated by culotte
stenting technique and other 128 lesions(61%) treated by stenting and kissing balloon
technique(S-KBT). We evaluated the incidence for MACE, which were deﬁned as
a combined end point of cardiac death, MI or TLR. During that period, the rate of
MACE, cardiac death, MI and TLR were 15.8%, 4.3%, 1.0%, 10.0% respectively. The
rate of MACE and TLR were not different between culotte stenting technique and
S-KBT (p¼0.35 and p¼0.29 respectively).
Conclusions: Long term outcome after PCI of bifurcation lesions with biodegradable
polymer coating BES might be promising.TCT-413
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Background: PCI to the left main coronary artery (LMCA) frequently involves the
bifurcation with signiﬁcant rates of repeat revascularisation. Single stent or 2 stent
techniques may be related to the pattern of plaque distribution using the Medina
system.
Methods: 254 patients underwent PCI to the distal LMCA, they were observed for
a combined adverse endpoint (CAE), repeat revascularisation, MI and all-cause
death. We categorised bifurcations into (Medina 1,1,1 and 0,1,1), both branch (BB)
involvement or only a single branch(SB) involvement (all other Medina groups).
Stent technique was categorised as simple (single stent) or complex (any 2 stent
technique).
Results: 161 (63%) patients had BB involvement. Follow-up 2.26 (3.1) years. Median
SYNTAX (IQR) 34.0(17.0) and 25.0(16.0), p<0.000. Median Additive Euro-
SCORE(IQR) was 7(6) and 6(5), p<0.000. Unadjusted CAE rates higher in the BB
group at 30 days (5.6% vs 3.2%, p ¼0.4), 6 months (16.1% vs 7.5%, p ¼ 0.05), 12
months (24.8% vs 12.9%, p ¼ 0.02) and long term (43.5% vs 29.0%, p ¼ 0.02).A
simple stent strategy was used in 59% of patients, 84% of the BB group. CAE rates were
not different between patients treated by simple and complex techniques. After
adjustment, BB disease and untreated severe right coronary artery(RCA) disease were
independently associated with an increase in CAE, adjusted hazard ratios (95% CI) 1.84
(1.24 to 2.72) and 1.80 (1.22 to 2.65).013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions







SConclusions: The presence of Medina classes 0,1,1 and 1,1,1, and the presence of
signiﬁcant RCA disease, but not stenting technique, are independent predictors of
increased rates of CAE following LMCA PCI.
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Background: Percutaneous coronary intervention (PCI) of complex true coronary
bifurcation lesions is challenging and whether to use a dedicated side branch stent is
still debatable. To date there is no published study evaluating the safety and efﬁcacy of
using an Everolimus-eluting stent (EES) in diabetic patients with true bifurcation
lesions treated with dedicated 2-stent (2S) vs. a provisional 1-stent (1S) technique. We
sought to compare outcomes with a dedicated 2S vs. provisional 1S strategy among
diabetic patients undergoing bifurcation stenting using EES.
Methods: We identiﬁed 202 diabetic patients with complex true bifurcation (Medina
classiﬁcation 1,1,1; 1,0,1; and 0,1,1) lesion who underwent bifurcation PCI using EES
from February 2010 to December 2011. The PCI strategy was either a provisional 1S
(n¼144) or dedicated 2S (n¼58) technique. Statistical analysis with all available
follow-up data were constructed for time-to-event variables with Kaplan-Meier
methodology and compared by log-rank test.
Results: The baseline characteristics were well matched between two PCI strategies.
In-hospital major adverse cardiac event (MACE) and postprocedure MI (CK-MB >3x
Normal, 8.33% vs. 10.34%, P¼0.65). At 1-year follow-up, MACE tended to be lower
for the 2S compared to the provisional 1S approach with the time to event analysis
depicted in Figure 1 (P¼0.08).JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: The conservative provisional 1S technique tended to have greater
MACE events compared to the dedicated 2S technique in diabetic patients after
treatment of complex true bifurcation lesions using newer generation EES.
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Background: Main vessel stenting with ﬁnal kissing balloon dilatation
(FKBD) is widely employed, but many technical variations are possible that
may affect the ﬁnal result. In this study, two different FKBD strategies were
investigated.
Methods: Finite element simulations were used to virtually deploy and post-dilate
three stent platforms within three bifurcation models, mimicking a range of
coronary bifurcation anatomies. Stents were sized according to the distal branch
diameter and deployed to a diameter of 3.2mm following the compliance charts.
During a second step, a shorter (but larger) balloon was used to post-dilate the
proximal stent segment. Two FKBD strategies were evaluated: “simultaneous
FKBD” (n¼27) and “modiﬁed FKBD” (n¼27). In the simultaneous FKBD, both
the side and main branch balloon were simultaneously inﬂated and deﬂated, with
a maximal balloon pressure of 12atm. In the modiﬁed FKBD, the side branch
balloon was inﬂated to a pressure of 12atm, and then deﬂated to 4atm. Subse-
quently, the main branch balloon was inﬂated to a pressure of 12atm. Eventually,
both balloons were fully deﬂated. The following quantitative measures were used
to compare both FKBD strategies: percentage of side branch obstruction, ellip-
ticity index (the ratio of the maximal to the minimal diameter in the proximal
stent segment) and percentage of malapposed struts (deﬁned as strut-artery
distance of more than 100 micron). The accuracy of the computer simulation
results was evaluated by comparing the virtually predicted stent deformations
with stent deformations observed during microCT visualised in-vitro bench
testing.
Results: Modiﬁed FKBD results in a lower ostial stenosis as compared to simulta-
neous FKBD (159% vs. 2011%, p<0.001) and also reduces the elliptical stent
deformation (ellipticity index ¼ 1.170.05 vs. 1.360.06, p<0.001). The amount of
malapposed stent struts was not inﬂuenced by the FKBD technique (modiﬁed FKBD:
6.33.6%, simultaneous FKBD: 6.43.4%, p¼0.212).
Conclusions: The modiﬁed FKBD procedure reduces the elliptical stent deformation
and optimises the side branch access while avoiding stent distortion within the main
vessel.
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Background: Scant data exist regarding the impact of diabetes mellitus (DM) status
on percutaneous coronary intervention (PCI) for left main (LM) coronary artery
disease. We sought to compare the impact of the presence of DM at baseline among
pts undergoing LM PCI on long-term ischemic outcomes.
Methods: Data from all consecutive patients from a single center were prospec-
tively collected. Pts were stratiﬁed according to the presence or absence of DM at
baseline. Coronary angiograms were analyzed by an independent angiographic
core laboratory and all events adjudicated by an independent clinical events
committee. Adverse ischemic outcomes were compared between the 2 groups up
to 6-year follow-up.
Results: Between Jan 2004 and Dec 2010, 1,528 consecutive pts underwent LM
PCI. DM was present in 369 (24.1%) pts. Pts with DM were more likely to have
increased weight, prior MI, hypertension, dyslipidemia and prior stroke. Angio-
graphically, DM pts presented more frequently with 3-vessel-disease, 1,1,1 medina
bifurcation and higher baseline SYNTAX score. Despite having more lesions treated
and more stents implanted, DM pts had higher residual SYNTAX score after
revascularization. One-year dual antiplatelet therapy compliance rates were high
among the complete cohort (95.3%) and similar between both groups. At 6-year
follow-up, no differences were seen in rates of all-cause death (6.0% vs. 4.7%,
p¼0.36) and deﬁnite/probable stent thrombosis (ST; 1.6% vs. 1.7%, p¼0.90)
between groups. However, DM pts had a higher rate of target lesion revasculari-
zation (TLR; 8.4% vs. 4.4%, p¼0.005), target vessel revascularization (TVR; 13.6%
vs. 8.1%, p¼0.003), and stroke (4.9% vs. 1.3%; p¼0.002). By multivariate analysis,acts/POSTER/Bifurcation and Left Main Interventions B129
